Why Abzena?
Our focused approach.
Over two decades of expertise in delivering bioconjugates for first-in-human studies and beyond:
360 George Patterson Blvd, Bristol, PA,19007, USA
Our Bristol, PA facility provides preclinical through commercial manufacturing support for bioconjugate drug programs including antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), Radio-conjugates (RDCs) and Peptide-conjugates (PDCs). With specialized handling controls in place to work with highly potent and cytotoxic materials, we can provide end-to-end development and manufacturing support for these innovative therapeutics.
Facility Highlights:
Watch our video below to learn more about our Bristol, PA facility.